Yarlagadda S. Babu
2012
In 2012, Yarlagadda S. Babu earned a total compensation of $602.2K as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Option Awards | $206,243 |
|---|---|
| Salary | $330,455 |
| Stock Awards | $52,976 |
| Other | $12,500 |
| Total | $602,174 |
Babu received $330.5K in salary, accounting for 55% of the total pay in 2012.
Babu also received $206.2K in option awards, $53K in stock awards and $12.5K in other compensation.
Rankings
In 2012, Yarlagadda S. Babu's compensation ranked 8,113th out of 11,487 executives tracked by ExecPay. In other words, Babu earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,113 out of 11,487 | 29th |
Division Manufacturing | 2,932 out of 4,253 | 31st |
Major group Chemicals And Allied Products | 774 out of 1,198 | 35th |
Industry group Drugs | 552 out of 920 | 40th |
Industry Biological Products, Except Diagnostic Substances | 87 out of 160 | 46th |
Source: SEC filing on April 10, 2015.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2012.
2012
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2012
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2012
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2012
David McCullough
BioCryst Pharmaceuticals